Background {#Sec1}
==========

Over the last decade the introduction of a series of infection control initiatives in acute healthcare environments in the UK has been associated with a dramatic decline in nosocomial infections caused by methicillin-resistant *Staphylococcus aureus* (MRSA) and *Clostridium difficile* \[[@CR1], [@CR2]\]. By contrast, the prevalence of bacteraemia caused by vancomycin-resistant enterococci (VRE) has been more resistant to change. Voluntary surveillance in England, Wales and Northern Ireland shows that bacteraemia caused by vancomycin-resistant *Enterococcus faecium* rose from 16 % to 24 % between 2010 and 2014 \[[@CR3]\], with a similar increase observed across Europe \[[@CR1]\]. VRE infections are associated with increased morbidity, mortality, healthcare costs and duration of hospital stay compared with vancomycin-susceptible (VSE) infections \[[@CR4], [@CR5]\].

Accurate identification of VRE reservoirs and transmission routes provides strategic direction to infection control interventions. Individuals in long-term care facilities (LTCF) frequently move through healthcare networks and are potential reservoirs for VRE \[[@CR6], [@CR7]\]. Pathogen transmission between people in long-term residential and acute care facilities is likely to be common \[[@CR8]\], but investigation is hampered by the low resolution of current typing methods, which cannot distinguish between isolates belonging to the same clone \[[@CR9], [@CR10]\]. Whole-genome sequencing (WGS) offers improved resolution, and has been used to delineate pathogen transmission of a range of bacterial species at local, national and global scales \[[@CR11]--[@CR14]\]. WGS also provides the sensitivity to detect genetic diversity of the same clone in an individual \[[@CR15], [@CR16]\]. Despite a growing body of data, microbial WGS has not been used to capture a dynamic picture of VRE carriage and transmission within and between interconnected healthcare facilities over time. The aim of this study was to define VRE carriage by residents of a LTCF over a 6-month period, and to use WGS to describe the genetic relatedness of isolates within and between residents, document whether VRE was transmitted in the LTCF over time, and compare these data with the genomes of bloodstream isolates in patients in the nearby acute hospital.

Methods {#Sec2}
=======

Study design, setting and participants {#Sec3}
--------------------------------------

We conducted a prospective observational cohort study of faecal VRE carriage in residents of a LTCF over a 6-month period in Cambridge, United Kingdom (UK). The LTCF had 105 beds and was subdivided into five physically separated units, to which residents were assigned based on cognitive impairment and physical disability.

Ethics, consent and permissions {#Sec4}
-------------------------------

All residents admitted to the LTCF during the study period were eligible for inclusion. Residents were excluded if they refused consent, were on an end-of-life care pathway, or were strongly resistant to basic personal care. Written informed consent was obtained from study participants prior to enrolment. For participants who lacked mental capacity, we obtained assent from their consultee. The study protocol was approved by the National Research Ethics Service (REC ref: 13/LO/1278) and the Cambridge University Hospitals NHS Foundation Trust Research and Development department (ref: A093007). All study procedures were performed in accordance with the Declaration of Helsinki.

Study procedures {#Sec5}
----------------

Data were collected from medical records and nursing care plans. This included demographics (age, gender, unit of residence), presence of co-morbidities (Charlson co-morbidity Index), presence of urinary or faecal incontinence or a urinary catheter, a history of VRE carriage or infection in the 12 months prior to enrolment, and infection and antibiotic use during the study. Data were also collected on healthcare contact (inpatient admission, outpatient clinic attendance, or general practitioner (GP) surgery visit) in the 12 months prior to enrolment and during the study period. Stool samples were collected at recruitment and then repeatedly (up to once a week) until the end of the study period, discharge from the LTCF or death.

Laboratory procedures {#Sec6}
---------------------

Stool samples were cultured within 24 h of collection on Monday to Friday, or within 48 h if collected at weekends. A 10 μL loopful was added to 5 mL Brain-Heart Infusion Broth (BHI) (Merck, Darmstadt, Germany) containing 3 μg/mL vancomycin (Sigma-Aldrich, St Louis, MO, US) and incubated at 37 °C in air at 100 rpm for 24 h. A total of 200 μL was plated onto Brilliance VRE agar (Oxoid, Basingstoke, UK) and incubated at 37 °C for 48 h. Purple or blue colonies (putative *E. faecium* or *E. faecalis*, respectively) were sub-cultured on Columbia Blood agar (CBA, Oxoid, Basingstoke, UK), incubated at 37 °C for 48 h, and the species confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) (Bruker Daltoniks, Bremen, Germany). Antimicrobial susceptibility was determined using the Vitek2 instrument (BioMérieux, Marcy l'Etoile, France) and the AST-P607 card. All stools positive for VRE were cultured for VSE. A 10 μL loopful was plated onto Brilliance UTI agar (Oxoid, Basingstoke, UK). Presumptive enterococci were sub-cultured on CBA containing a 5 μg vancomycin disc (Oxoid, Basingstoke, UK). Colonies growing at the edge of the zone of inhibition were selected for identification and antimicrobial susceptibility testing as above.

Bacterial sequencing and analysis {#Sec7}
---------------------------------

Genomic DNA was extracted from a pure bacterial culture based on a single colony using the QIAxtractor (QIAgen, Hilden, Germany). Library preparation was based on the Illumina protocol, and sequencing was performed on an Illumina HiSeq2000 with 100-cycle paired-end runs. Sequence reads were assembled using Velvet and mapped to the *E. faecium* reference genome Aus0004 (European Nucleotide Archive (ENA) accession number CP003351) using SMALT \[[@CR17]\]. Mobile genetic elements (MGEs) were identified (genes annotated as plasmid-, phage-, IS- or transposon-associated) and removed. Gubbins was used to remove regions of recombination \[[@CR18]\], creating a core genome. Core genome single nucleotide polymorphisms (SNPs) were used to estimate maximum likelihood trees using RAxML \[[@CR19]\] with 100 bootstraps and a midpoint root. The multilocus sequence type (ST) was derived from sequence data using an in-house script and the MLST database \[[@CR20]\]. *vanA* and *vanB* were detected by *in silico* polymerase chain reaction (PCR) using published primers \[[@CR21], [@CR22]\]. Isolates positive for *vanA* were mapped to a Tn*1546* reference (ENA accession number M97297). The nucleotide sequences of the *Tn1546* transposon, and those up- and downstream of the transposon, in each isolate were identified as described by Howden *et al.* \[[@CR23]\] using Artemis \[[@CR24]\], and queried against each other and nucleotide databases using BLAST. Isolates positive for *vanB* were mapped to Aus0004 Tn*1549* \[[@CR25]\] and up- and downstream nucleotide sequences identified as for *vanA.* Plasmid replicon (*rep)* typing was performed using *in silico* PCR and published primers \[[@CR26], [@CR27]\].

Whole-genome sequences were available for 45 *E. faecium* bloodstream isolates collected between January and December 2012 at the Cambridge University Hospitals NHS Foundation Trust (CUH) (S. Peacock, personal communication). These consisted of the first stored isolate for 45 patients, identified using the diagnostic microbiology laboratory database at CUH. Information on date of isolation and patient location was available. These isolates had been sequenced as part of a previous study, approved by the National Research Ethics Service (REC ref: 12/EE/0439) and the Cambridge University Hospitals NHS Foundation Trust R&D Department (ref: A092685). Sequence data for all study isolates have been submitted to the European Nucleotide Archive with the accession numbers shown in Additional file [1](#MOESM1){ref-type="media"}.

Results {#Sec8}
=======

Baseline characteristics {#Sec9}
------------------------

Forty-five of the 90 (50 %) eligible residents were recruited. Participants had a median age of 82 years (range, 40--104 years; interquartile range (IQR), 71--87 years), and 29 (64 %) were female. Three participants were lost to follow-up during the study because of death (n = 2) or transfer to another facility (n = 1). The median duration of residence in the study facility at the time of recruitment was 16 months (range, 5 days to 54 months; IQR, 6--41 months). The median Charlson co-morbidity Index was 6 (range, 0--10). Thirty-three (73 %) participants were incontinent of urine and faeces (three of whom had an indwelling urinary catheter), and two (5 %) participants had urinary incontinence alone. One participant (P7) had a history of VRE infection (of the urinary tract) in the 12 months prior to recruitment.

The majority of residents (38/45, 85 %) had previously resided in another healthcare facility. Movement of participants through the healthcare network is summarised in Table [1](#Tab1){ref-type="table"}. Healthcare contact was extensive, with more than half of participants (n = 26, 58 %) having at least one episode of healthcare contact (hospital admission, outpatient clinic attendance or visit to a GP surgery) in the 12 months prior to recruitment, and six participants having between 1 and 5 (total of 19) episodes of healthcare contact during the study. There were 61 infections recorded in 23 (51 %) participants (median, 2 infections per case; range, 1--5) during the 6-month study period, although none of these were associated with VRE. The most common site of infection was the urinary tract (n = 33, 54 %), followed by respiratory tract (n = 16) and skin and soft tissue infection (n = 8). The focus of infection in four cases was not specified. All participants with a urinary catheter had at least one urinary tract infection recorded during the study period. The 23 participants received 63 courses of antibiotics (median, 2 courses; range, 1--6).Table 1Summary of healthcare contact for 45 study participantsHealthcare contactFrequencyPlace of residence before admission to study facility (n, %) Home7 (46.7 %) Hospital17 (37.8 %) Residential care^a^21 (15.6 %)Participants with healthcare contact 12 months before recruitment (n, %)26 (57.7 %) Total number of episodes60  Median (range) per participant2 (1--4)  Inpatient admission^b^23/60 (38.3 %)  Outpatient attendance^c^35/60 (58.3 %)  General practice attendance^d^2/60 (3.3 %)Participants with healthcare contact during study (n, %)6 (13.3 %) Total number of episodes19 Median (range) per participant2 (1--5)  Inpatient admission^b^8  Outpatient attendance^c^11  General practice attendance^d^0^a^Residential care -- any nursing or residential home^b^Admission to hospital for at least an overnight stay^c^Outpatient department visit or visit to emergency department not resulting in admission^d^Visit to GP surgery

Carriage of vancomycin-resistant *E. faecium* by study participants {#Sec10}
-------------------------------------------------------------------

A total of 693 stools were collected over the 6-month study period, at a frequency of at least 1 week apart. Fifty-one stools from three participants (7 %) were positive for VRE, all of which were *E. faecium* (n = 24, 21 and 6 positive samples for P7, P15 and P31, respectively*)*. This included the participant (P7) who had a past history of VRE infection. Figure [1a](#Fig1){ref-type="fig"} shows the timing of positive and negative samples for each of the three cases. STs of the 51 VRE isolates were identified from the sequence data, which assigned the isolates to six STs (ST18, ST80, ST117, ST203, ST780 and ST787). A notable feature was that two residents (P7 and P15) each carried multiple STs with no overlap in STs between the two cases: P7 carried ST80 (isolated from 20 stool samples), ST117 (n = 2), and ST203 (n = 2), and P15 carried ST787 (isolated from 18 stool samples), ST18 (n = 2), and ST780 (n = 1). The third VRE positive resident (P31) carried a single ST that was assigned to ST203. *In silico* PCR demonstrated that the 51 VRE isolates carried *vanA.*Fig. 1Epidemiological and genomic description of VRE isolated from stool of study participants*.* **a** Timeline of VRE positivity for three study participants, with week indicated at the bottom. Red, VRE isolated; blue, VRE not isolated; black, discharged; line, no sample available; black circle, admitted to local NHS Trust for at least 24 h. **b** Maximum likelihood tree based on core genome SNPs of 51 VRE isolates from three study participants. Each participant is identified by a unique colour, and labels show the participant number, week of isolation and ST

A phylogenetic tree for the 51 VRE isolates based on SNPs in the core genome is shown in Fig. [1b](#Fig1){ref-type="fig"}. P7 carried four genetically distinct lineages (two of which belonged to ST80), and P15 carried three, with no evidence for carriage of related strains by these two residents. The majority of VRE isolates from P7 and P15 each belonged to a single lineage (18/24 (75 %), and 18/21 (86 %)), with a median pairwise SNP difference within each of these two clusters of 3 (range, 0--6) and 1 (range, 0--6), respectively. P7 and P31 both carried VRE isolates belonging to ST203, but these were genetically distinct (median SNP difference of 74; range, 73--74), excluding transmission between them (Fig. [1b](#Fig1){ref-type="fig"}). The VRE-positive participants resided in different units. All three VRE positive participants had healthcare contact in the 12 months prior to the study, including hospital admission (5 episodes), outpatient clinic attendance (3 episodes) or attendance at Accident and Emergency Department without admission (1 episode), and one VRE positive participant (P7) had healthcare contact during the study consisting of four inpatient admissions and five outpatient clinic attendances.

To identify the genomic location of the *vanA* transposon and its relatedness within and between participants, we analysed the region of sequence adjacent to the transposon in each isolate. This was possible for 30 isolates from the three participants and included four STs (ST80, 117, 203 and 787). The highest match in the blast database predicted that the transposon was present on the pLG1 mega-plasmid (accession numbers HM565234 and HM565172) \[[@CR28]\] for 29/30 isolates, (100 % ID up to 5998 bp) and was adjacent to a gene encoding a cadmium efflux system accessory protein. Blast analysis of the remaining isolate (from P15) gave multiple matches to regions in *E. faecium* strain DO plasmid 2 (accession number CP003585) \[[@CR29]\], p5753cB (GQ900487) \[[@CR30]\], pS177 (HQ115078) \[[@CR31]\], pF856 (JQ663598) \[[@CR32]\] and pRUM (AF507977) \[[@CR33]\]. To analyse the similarity between the putative pLG1 plasmid transposons, sequence reads for the 29 genomes were mapped to a reference *vanA* transposon. This revealed that the six genomes from P31 isolates shared 100 % identity with the reference, while 23 isolates from P7 were identical with the exception of the same SNP at position 8634. We also characterised variation in plasmids using *rep* typing, which demonstrated the presence of seven types (10, 11, 14, 17, 18, 20 and pMG1) with a range of 2--7 *rep* types per isolate. There was variation in the presence of *rep* types, both within and between individual STs, which extended to variation within the same individual.

Genetic relatedness between vancomycin-resistant and -susceptible *E. faecium* {#Sec11}
------------------------------------------------------------------------------

All 51 VRE-positive stools were cultured for the presence of VSE, which was identified in 25 (49 %) stools from the three participants (n = 9, 15 and 1 for P7, P15 and P31, respectively). MLST was identified from the sequence data, which assigned the isolates to nine STs. As before, P7 and P15 carried multiple STs: P7 carried ST80, ST117 and ST203 (mirroring the VRE STs in this individual) together with ST127 (a single locus variant of ST80), while P15 carried ST787 and ST18 (mirroring the VRE STs in this individual), together with two STs not represented in the VRE population (ST206 and ST17). By contrast, the VSE carried by P31 was assigned to an ST that was different from their VRE strain (ST328). *Rep* typing of the VSE isolates revealed the same *rep* types found in the VRE isolates, with a median of 6 *rep* types per isolate (range, 2--7). No *rep* types were specific to VRE or VSE. One phenotypically vancomycin susceptible isolate carried the *vanB* gene (P15-week(W)12-ST17) based on *in silico* PCR. This isolate lacked the *vanR* and *vanS* genes from whole genome sequence data and from the assembled Tn*1549* transposon. Loss of *vanR* and *vanS* from the van operon resulting in a susceptible phenotype has been described previously for *vanA*-positive isolates \[[@CR32], [@CR34]\]. A phylogenetic tree of the 51 VRE and 25 VSE isolates based on core genome SNPs is shown in Additional file [2](#MOESM2){ref-type="media"}. This showed that the VSE carried by P7 and P15 were closely related to their resident VRE populations demonstrating possible *in vivo* acquisition or loss of resistance, whilst as expected the VSE carried by P31 was not closely related to their VRE.

Relatedness of *E. faecium* within a healthcare network {#Sec12}
-------------------------------------------------------

Sequence data for VRE isolates from study participants were compared with that for 45 *E. faecium* isolates from patients with bloodstream infection at the nearby acute hospital during 2012. Phenotypic susceptibility testing demonstrated that 41 isolates were vancomycin-resistant (all of which carried *vanA*), and four isolates were vancomycin-susceptible. A phylogenetic tree of the 51 VRE from stool and 45 hospital isolates based on core genome SNPs showed that carriage isolates from the three study participants were interspersed throughout the tree (Fig. [2a](#Fig2){ref-type="fig"}). There were several examples where isolates from the LTCF and hospital were highly related (Fig. [2b](#Fig2){ref-type="fig"} and [c](#Fig2){ref-type="fig"}) which included two sets of isolates from P15 and one from P7. One of these clusters included two VRE isolates from P7 that were closely related to six hospital-associated VRE bloodstream isolates cultured in 2012 (minimum pairwise SNP difference of 4; range, 4--15) and one from P15 with a minimum pairwise SNP difference of 6 (Fig. [2b](#Fig2){ref-type="fig"}). P7 was not admitted to CUH during 2012, but was admitted twice during 2013 (for 1.5 and 2 months, respectively) and was also admitted to CUH on four further occasions during the study period. Comparison of transposons and sequences downstream of their insertion between the LTCF and hospital isolates was possible for five of these six hospital isolates. This revealed that the transposon sequences and downstream sequences for 4/5 were identical to the two isolates from P7. The fifth hospital isolate had two SNPs and an 89 bp insertion in the sequence downstream of the transposon. A second cluster involved VRE carried by P15 and VRE bloodstream isolates from two patients, the closest of which also differed by six SNPs (Fig. [2c](#Fig2){ref-type="fig"}). A case note review revealed that P15 was admitted to the CUH on three occasions in 2012, and had ampicillin-resistant *E. faecium* isolated from urine during the third admission. P15 was an inpatient at the same time, but not on the same ward as the two patients with bloodstream infection in this cluster (Fig. [2c](#Fig2){ref-type="fig"}). The four vancomycin-susceptible isolates were found to be carrying *vanB* by *in silico* PCR. Additionally, we noted that the single isolate positive for *vanB* isolated from P15 clustered with the four *vanB* positive hospital-associated bloodstream isolates*,* the closest of which was 12 SNPs different based on a core genome comparison. Mapping of these isolates to the Aus0004 Tn*1549* transposon demonstrated that the transposons and their downstream sequences were identical to that of the *vanB-*positive isolate from the LTCF.Fig. 2Phylogeny and relatedness *of Enterococcus faecium* isolated from networked healthcare facilities. **a** Maximum likelihood tree of 51 VRE positive isolates cultured from the stool of three study participants labelled by participant and week (dark blue), one VSE carriage isolate from the LTCF carrying *vanB* (light blue), 41 VRE isolates from patients with bloodstream infection in 2012 at the nearby acute NHS Trust (orange) and four VSE isolates carrying *vanB* from patients with bloodstream infection (brown). **b** Enlarged view of closely related isolates from P7 and P15 and isolates associated with bloodstream infection. **c** Enlarged view of tree containing closely related isolates from P15 and isolates associated with bloodstream infection

Discussion {#Sec13}
==========

Residents of LTCFs are at increased risk of infection from a range of multidrug-resistant organisms (MDRO) compared with the general population \[[@CR35], [@CR36]\]. This may be related to several factors, including frequent healthcare contact and high levels of antibiotic use. Furthermore, LTCF are often akin to a home environment, where screening for MDROs is not routinely performed and isolation of residents may be detrimental to care. The combination of these factors represents a perfect storm for the control of MDRO.

In this study, we focused on carriage and transmission of VRE, a nosocomial pathogen that has remained a persistent problem despite the raft of infection control measures introduced into UK hospitals to reduce the prevalence of MRSA and *C. difficile*. We found that 7 % of residents carried VRE in their stool on at least one occasion, a finding consistent with previous studies in Israel, Germany and the United States \[[@CR6], [@CR7], [@CR37]\]. Our longitudinal study design allowed us to investigate carriage over time. This identified variability in the duration of carriage, with two long-term carriers and one individual who appeared to lose VRE carriage during the study. Intermittent and transient VRE carriage has been described previously \[[@CR38], [@CR39]\]. Genome sequencing was used to determine the genetic relatedness of VRE isolates. The advantage of doing so became apparent on comparing this with the results of *in silico* MLST. Reliance on MLST could have led to an incorrect link being made between two residents (P7 and P31) who both carried VRE ST203 which were not closely related on sequencing.

Sequencing of VSE in VRE-positive participants demonstrated that two individuals carried multiple VSE lineages that were closely related to their VRE isolates. This is consistent with the findings of Howden *et al*. \[[@CR23]\] that VRE and VSE across the species are not genetically distinct. VSE strains may have gained resistance via horizontal gene transfer from colonising VRE lineages. We identified identical *vanA* transposons and insertion sites in multiple STs from P7, suggesting possible sharing of the *vanA* mobile genetic element within patients. *Rep* types were not distinct between VRE and VSE populations, and varied within STs, suggesting the presence of highly mobile plasmids.

A combination of epidemiological and sequence data allowed us to consider the source of VRE acquisition. While the LTCF environment might be expected to lead to multiple transmission events, there was no evidence for direct transmission of VRE within the study facility. Prior evidence for transmission of VRE in LTCFs is limited, with a single point prevalence study suggesting transmission between 3/188 residents based on pulse field gel electrophoresis \[[@CR40]\]. Instead, the source of acquisition may be linked to the frequent interaction with healthcare facilities as two persistent carriers with a history of extensive healthcare contact carried multiple VRE lineages, the majority of which have been associated previously with the healthcare setting based on MLST \[[@CR41]\]. This indicates long-term carriage (over 6 months) of hospital-associated lineages in community-based care facilities.

Comparison of WGS data for VRE from the LTCF and the acute hospital to which the participants are referred provided the opportunity to compare the relatedness of isolates drawn from different parts of the same healthcare network. This demonstrated that isolates associated with bloodstream infection were highly related to those carried by the LTCF residents. Direct transmission between the study participants and hospital patients is unlikely, but two of the participants carrying VRE were admitted to the hospital within a relevant timeframe for exposure to the circulating VRE lineages. Furthermore, repeated admission of the study participants represents a mechanism for perpetuation of these lineages. The sequence downstream of the *vanA* transposon in two of the LTCF isolates was identical to four of five hospital isolates closely related to them, providing further evidence for transmission of VRE from hospitals to community care facilities. Additionally, this region of sequence in the genetically more stable *vanB* Tn1549 transposon of the LTCF isolate matched those from the hospital also carrying *vanB*.

Our study has several limitations. First, only half of the residents in the study facility agreed to participate in the study, which may have obscured transmission events between study participants and individuals who were not recruited. Second, we only sequenced a single colony from each stool sample, which may have affected our ability to detect carriage of more than one VRE lineage. However, this risk was mitigated by repeated sampling of individual patients over time, which did demonstrate carriage of multiple lineages in long-term carriers. Evidence for concurrent carriage of multiple HCA lineages of enterococci is limited, but has implications for current screening and WGS techniques based upon single cultures. Finally, we only had access to the genome sequence of bloodstream isolates from the acute hospital, which may not be fully representative of the carriage population in this setting. Despite this, we were still able to provide evidence demonstrating that clones had been shared between the hospital and LTCF.

Conclusions {#Sec14}
===========

This study has confirmed that a proportion of residents in a community-based long-term care facility carried VRE in stool, genome sequencing of which demonstrated multiple lineages in some cases but no evidence for transmission between residents. This population frequently requires admission to hospital, where they may acquire nosocomial pathogens as well as transmit existing strains to hospital patients and shed organisms into the environment. A genome comparison of VRE carriage isolates in the LTCF and VRE bloodstream isolates confirmed that VRE in the two populations were highly related. This shared population is likely to reflect two-way transmission. Tackling multidrug-resistant pathogens in hospitals requires an understanding of reservoirs and transmission of bacteria within highly connected healthcare facilities, together with infection control policies that consider this as a continuum.
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